PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,055,699 | -76.7% | 34,410 | -57.4% | 0.01% | -82.8% |
| Q3 2021 | $4,528,000 | +117.6% | 80,849 | +135.8% | 0.03% | +107.1% |
| Q2 2021 | $2,081,000 | +679.4% | 34,287 | +800.9% | 0.01% | +600.0% |
| Q1 2021 | $267,000 | -96.1% | 3,806 | -96.7% | 0.00% | -96.5% |
| Q4 2020 | $6,803,000 | +2.4% | 113,692 | +2.9% | 0.06% | +3.6% |
| Q3 2020 | $6,641,000 | +1853.2% | 110,457 | +1370.2% | 0.06% | +685.7% |
| Q4 2019 | $340,000 | -40.0% | 7,513 | -49.6% | 0.01% | -58.8% |
| Q1 2019 | $567,000 | -51.6% | 14,903 | -45.2% | 0.02% | -67.9% |
| Q4 2018 | $1,171,000 | -57.6% | 27,216 | -51.5% | 0.05% | -11.7% |
| Q3 2018 | $2,759,000 | – | 56,126 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |